Michele A. Poepping-Faulkner, PharmD, RPh
Michele A. Poepping-Faulkner, PharmD, RPh

Michele A. Poepping-Faulkner, PharmD, RPh

Professor
School of Pharmacy and Health Professions

Academic Appointments

Department

  • Pharmacy Practice

Position

  • Professor

Secondary Appointment

  • School of Medicine

Education

  • Doctor of Pharmacy Degree, Creighton University School of Pharmacy and Health Professions August 1990-May 1990
  • Pharmacy Practice Residency (PGY-1 equivalent) , SW Texas Methodist Hospital July 1994-July 1995
  • Creighton University,Pre-Pharm,1988-1990
  • Creighton University,PharmD,1990-1994

Certifications

Psychological First Aid, University of Nebraska Public Policy Center - November 18, 2010 eFellows Fellowship (Information Technology) Creighton University Academic Development and Technology Center - August 2008-May 2009 Pharmacy-Based Immunization Delivery Certificate Program American Pharmacists Association Salt Lake City, Utah - August 25-27, 2000

Publications and Presentations

Books

  • Faulkner MA. Parkinson Disease. In: Scott S. Sutton, editor. McGraw-Hill's NAPLEX® Review Guide, 2e. New York, NY: McGraw-Hill; 2014. http://tinyurl.com/pongan5. Accessed May 29, 2015. (Chapter Update)., McGraw-Hill, 2015
  • Coppard BM, Coover K, Faulkner M. Use of Medications by Elders. In: René L. Padilla, Sue Byers-Connon, Helene L. Lohman, editors. Occupational Therapy With Elders. Strategies for the COTA. Maryland Heights, MO: Elsevier Mosby; 2011. p. 169-181., Elsevier/Mosby, 169-181, 2011
  • Faulkner MA. Pharmacotherapy in the Context of Family for Chronic Mental Illness. In: Martha Craft-Rosenberg, Shelley-Rae Pehler, editors. Encyclopedia of Family Health. Thousand Oaks, CA: SAGE Publications, Inc.; 2011. p. 824-828., Sage, 824-828, 2011
  • Faulkner MA. Pharmacotherapy in the Context of Family for Chronic/Terminal Physical Illness. In: Martha Craft-Rosenberg, Shelley-Rae Pehler, editors. Encyclopedia of Family Health. Thousand Oaks, CA: SAGE Publications, Inc.; 2011. p. 828-833., Sage, 828-833, 2011
  • Faulkner M, Wilson A. Nervous System. In: Rhonda Jones, Raylene Rospond, editors. Patient Assessment in Pharmacy Practice. Baltimore, MD: Lippincott Williams & Wilkins; 20XX. (In Press)., Lippincott Williams & Wilkins

Articles

  • Faulkner MA. Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndrome. Ther Clin Risk Manag 2015;8:905-14. (Invited), Therapeutics and clinical risk management, 8, 905-914, 2015
  • Faulkner MA. Risk of Progressive Multifocal Leukoencephalopathy (PML) in Patients with Multiple Sclerosis. Expert Opinion on Drug Safety 2015;14:1737-48., Expert Opinion on Drug Safety, 14, 1737-48, 2015
  • Faulkner MA. Perampanel: A new agent for the adjunctive treatment of partial seizures. Am J Health-Syst Pharm 2014;71:191-8., American Journal of Health-System Pharmacy, 71, 191-198, 2014
  • Faulkner MA. Safety overview of FDA approved medications for the treatment of the motor symptoms of Parkinson’s disease. Exp Opin Drug Saf 2014 ;13(8):1055-69., Expert Opinion on Drug Safety, 13(8), 1055-1069, 2014
  • Singh S, Agarwal S, Faulkner M. Refractory status epilepticus. Ann Indian Acad Neurol 2014;17 (Supp 1):S32-S36., Annals of Indian Academy of Neurology, 17, S32-S36, 2014
  • Faulkner MA, Burke RA. Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel. Expert Opin Drug Saf 2013;12(6):847-55. (Invited), Expert Opinion on Drug Safety, 12(6), 847-855, 2013
  • White ND, Lenz TL, Skrabal MZ, Faulkner MA, Skradski JJ, Southard LA, Popken DE. Comparison of cardiovascular risk calculation tools in pharmacy practice. JAPhA 2013;53(4):408-13., Journal of American Pharmacists' Association, 53(4), 408-413, 2013
  • Faulkner MA, Singh SP. Neurogenetic disorders and treatment of associated seizures. Pharmacotherapy 2013;33(3):330-43., Pharmacotherapy, 33(3), 330-343, 2013
  • Lenz TL, Gillespie ND, Skrabal MZ, Faulkner MA, Skradski JJ, Ferguson LA, et al. Using employee experts to offer an interprofessional diabetes risk reduction program to fellow employees. J Interprof Care 2013;2:197-9., Journal of Interprofessional Care, 2, 197-199, 2013
  • Lenz TL, Gillespie ND, Skrabal MZ, Faulkner MA, Skradski JJ, Qi Y, Coleman AW. Health-related quality of life impact in employees participating in a pharmacist-run risk reduction program. Innovations in Pharmacy 2012;3(4):Article 94., Innovations in Pharmacy, 3(4), 94, 2012
  • Burke RA, Faulkner MA. Review of the Treatment of Restless Legs Syndrome: Focus on Gabapentin Enacarbil. J Cent Nerv Syst Dis 2012;4:147-56. (Invited), Journal of Central Nervous System Disease, 4, 147-156, 2012
  • Lenz TL, Gillespie ND, Faulkner MA, Skrabal MZ, Skradski JJ, Qi Y, Larson JC. Lifestyle medicine-related cardiovascular risk factor changes in employees participating in a pharmacist-run risk reduction program. Innovations in Pharmacy 2012;3(4):Article 93., Innovations in Pharmacy, 3(4), 93, 2011
  • Burke RA, Faulkner MA. Gabapentin enacarbil for the treatment of restless legs syndrome (RLS). Expert Opin Pharmacother 2011;12(18):2905-14., Expert opinion on pharmacotherapy, 12(18), 2905-2914, 2011
  • Faulkner MA. Ezogabine for the adjunctive treatment of partial onset seizures in adults with epilepsy. Clin Med Insights:Therapeutics 2011;3:441-448. (Invited), Clinical Medicine Insights: Therapeutics, 3, 441-448, 2011
  • Faulkner MA, Tolman JA. Safety and efficacy of vigabatrin for the treatment of infantile spasms. J Cent Nerv Syst Dis 2011;3:199-207. (Invited), Journal of Central Nervous System Disease, 3, 199-207, 2011
  • Tolman JA, Faulkner MA. Treatment Options for Refractory and Difficult to Treat Seizures – Focus on Vigabatrin. Ther Clin Risk Manag 2011;7:367-375. (Invited), Therapeutics and clinical risk management, 7, 367-375, 2011
  • Ryan-Haddad A, Coover K, Faulkner M. Development and incorporation of an interprofessional experience into a geriatric pharmacy elective: the first year experience. Currents in Pharmacy Teaching and Learning 2011;3(2):116-122. (Invited), Currents in Pharmacy Teaching and Learning, 3(2), 116-122, 2011

Publications

  • Published Interview: Stohs-Krause, H. Looking At Two High-Paying Careers With Very Different Gender Breakdowns. NET (PBS/NPR) 11 Oct, 2013. Available online at http://netnebraska.org/article/news/looking-two-high-paying-careers-very-different-gender-breakdowns., 2013
  • Published Interview: Ruggles, R. One-two punch vs. Parkinson’s: meds and a machine. The Omaha World Herald 1 July, 2013: Print., Omaha World-Herald, 2013

Editing and Reviews

  • Faulkner MA. Rev. of Handbook of Epilepsy Treatment, 3rd Edition, by Simon Shorvon. Ann Pharmacother 2011;45:549-550. (Invited), Annals of Pharmacotherapy, 45, 549-550, 2011

Presentations

  • Faulkner M, Bainbridge J. Complex cases in neurology: the essentials you need to know. APhA Annual Meeting and Exposition. Baltimore, MD. March 7, 2016. ACPE# 0202-0000-16-019-L01-P., 2016
  • Faulkner MA, Makhija K, Smith AN. Effect of plasmapheresis on levetiracetam and lacosamide serum concentrations. American Society of Health-System Pharmacists Summer Meeting and Exhibition. Denver, CO. June, 2015., 2015
  • Agrawal S, Turco L, Goswami S, Faulkner M, Singh S. Yield of monitoring in an adult epilepsy monitoring unit. American Academy of Neurology. Washington, DC. April, 2015. Abstract: Available at http://tinyurl.com/o7dfm67., 2015
  • Chan J, Chen J, Makhija K, Faulkner M, Singh S. Gender differences in the incidence of psychiatric co-morbidity in patients with epilepsy. American Academy of Neurology. Washington, DC. April, 2015. Abstract: Available at http://tinyurl.com/o7dfm67., 2015
  • Threlkeld JA, Katsavelis D, Faulkner MA, Huben NB. The effect of walking speed and dopaminergic medication on knee muscle performance in people with Parkinson’s disease-related fatigue. 7th World Congress of Biomechanics. Boston, MA. July, 2014. Abstract: Threlkeld JA, Katsavelis D, Faulkner MA, Huben NB. The effect of walking speed and dopaminergic medication on knee muscle performance in people with Parkinson’s disease-related fatigue. Available online: http://tinyurl.com/or6kwcy., 2014
  • Faulkner MA, Marasco R. Improving the Management of Parkinson’s Disease. APhA Annual Meeting and Exposition. Orlando, Florida. March 31, 2014. ACPE# 0202-0000-14-042-L01-P. (Invited), 2014
  • Singh S, Sankaraneni RR, Faulkner M, Karimi S. Clinical experience with felbamate in adults with intractable epilepsy & static encephalopathy. American Epilepsy Society. Washington, DC. December 2013. Abstract: Singh S, Sankareneni RR, Faulkner M, Karimi S. Clinical experience with felbamate in adults with intractable epilepsy & static encephalopathy. Available online: http://www.aesnet.org/go/publications/aes-abstracts/abstract-search/mode/display/st/singh%20and%20faulkner%20and%20felbamate/sy/2013/sb/All/id/1751302., 2013
  • Managing Medications in Neurological Disorders-A Practical Approach. Neurology of Today: A Practical Approach for Primary Care. Omaha, Nebraska (Hilton Omaha Hotel). November 8, 2013. CE Program (ACPE # 0839-0000-13-028-L04-P) (Invited), 2013
  • Management of Non-motor Symptoms. Second Annual Advances in Parkinson’s Care. Omaha, Nebraska (Double Tree Hotel). October 11, 2013. CE Program (Physicians, Nursing, OT and PT) (Invited), 2013
  • Faulkner MA. The Unique Challenges of Managing Parkinson’s Disease: Actionable Insights for Pharmacists. (Program co-developed with M. Jann, PharmD and J. Sinopoli, RPh). University of Tennessee College of Pharmacy. ACPE# 0064-0000-13-209-L01-P. (Invited), 2013
  • Faulkner MA. The Unique Challenges of Managing Parkinson’s Disease: Actionable Insights for Pharmacists. (Program co-developed with M. Jann, PharmD and J. Sinopoli, RPh). University of Tennessee College of Pharmacy. ACPE# 0064-0000-13-209-L01-P. (Invited), 2013
  • Beyond Tremor: Identification and Treatment of Non-Motor Symptoms in the Parkinson Disease Patient. School of Pharmacy and Health Professions Alumni Weekend. Omaha, Nebraska. September 20, 2013. CE Program (ACPE # 0839-0000-13-025-L04-P) (Invited), 2013
  • Faulkner MA. The Unique Challenges of Managing Parkinson’s Disease: Actionable Insights for Pharmacists. (Program co-developed with M. Jann, PharmD and J. Sinopoli, RPh). University of Tennessee College of Pharmacy. ACPE# 0064-0000-13-209-L01-P. (Invited), 2013
  • Faulkner MA. The Unique Challenges of Managing Parkinson’s Disease: Actionable Insights for Pharmacists. (Program co-developed with M. Jann, PharmD and J. Sinopoli, RPh). University of Tennessee College of Pharmacy. ACPE# 0064-0000-13-209-L01-P. (Invited), 2013
  • Faulkner MA, Bremer KL. Efficacy evaluation of a modified onabotulinumtoxinA injection regimen in patients with chronic migraine headaches. American Society of Health-System Pharmacists Summer Meeting and Exhibition. Minneapolis, MN. June, 2013., 2013
  • Marky B, Faulkner M, Freberg J. A case of familial myasthenia gravis and azathioprine- induced bone marrow toxicity in multiple family members. American Academy of Neurology 65th Annual Meeting. San Diego, CA. June, 2013, 2013
  • Parkinson’s Disease: Q&A With the Pharmacist. Southwest Omaha Parkinson’s Disease Support Group. Omaha, Nebraska. June, 2013. (Laypersons), 2013
  • Parkinson’s Disease: Q&A With the Pharmacist. Lakeside Parkinson’s Disease Support Group. Omaha, Nebraska (Lakeside Village). May, 2013. (Laypersons), 2013
  • An Introduction to Parkinson’s Disease. Orientation for New Nurses. Alegent-Creighton Health/CUMC., 2013
  • An Introduction to Parkinson’s Disease. Orientation for New Nurses. Alegent-Creighton Health/CUMC., 2012
  • Faulkner MA, Sinopoli J (in conjunction with Chen, J). Navigating the Complicated Treatment Regimens of Parkinson’s Disease: Challenges and Opportunities for Pharmacists. University of Tennessee College of Pharmacy (Webinar). December 6, 2012. ACPE #0064-0000-12-218-L01-P. (Invited), 2012
  • Perampanel (Fycompa®). Epilepsy Conference. November 20, 2012., 2012
  • Pharmacologic Treatment of Parkinson’s Disease and Epilepsy: An Update. Neurology of Today: Update for Primary Care. Omaha, Nebraska (Marriott Regency). November, 2012. CE Program (ACPE # 0839-0000-12-013-L04-P) (Invited), 2012
  • Parkinson’s Disease: Medication Therapy. Bellevue Parkinson’s Disease Support Group. Bellevue, Nebraska (Bellevue Medical Center). September, 2012. (Laypersons), 2012
  • Parkinson’s Disease Update. Parkinson’s Support Group (Omaha). Omaha, Nebraska (New Cassel Retirement Center). August, 2012. (Laypersons), 2012
  • Ezogabine (Potiga®). Epilepsy Conference. June 19, 2012., 2012
  • Faulkner MA, Gillespie ND, Lenz TL, Skrabal MZ. Effect of a pharmacist-run worksite diabetes management program on employee productivity: a pilot study. American Society of Health-System Pharmacists Summer Meeting and Exhibition. Baltimore, MD. June, 2012., 2012
  • Parkinson’s Disease Q&A. Parkinson’s Center of Nebraska (statewide teleconference). Omaha, Nebraska. May, 2012 (Laypersons), 2012
  • Faulkner MA, Gillespie N, Skrabal M, Lenz T, Skradski J. Creation of a pharmacist‐driven risk reduction program for University employees with diabetes. 46th American Society of Health-System Pharmacists Annual Meeting and Exhibition. New Orleans, LA. December,2011. Abstract: Faulkner MA, Gillespie N, Skrabal M, Lenz T, Skradski J. Creation of a pharmacist‐driven risk reduction program for University employees with diabetes. Available online: http://www.cmcgc.com/media/handouts/311204/Professional_Poster_Abstracts.pdf., 2011
  • Antony A, Alareddy A, Faulkner M, Singh SP. Epilepsy in adult patients with Angelman syndrome. 65th American Epilepsy Society Annual Meeting. Baltimore, MD. December, 2011. Abstract: Antony A, Alareddy A, Faulkner M, Singh SP. Epilepsy in adult patients with Angelman syndrome. Available online: http://www.aesnet.org/go/publications/aes-abstracts/abstract-search/mode/display/st/*/sy/2011/sb/all/page/83/id/14578., 2011
  • Christensen K, Faulkner M. Development of an interactive electronic health record as a training tool for pharmacy students. Electronic Health Record Education: Building a Tech-Savvy Workforce. Lincoln, Nebraska. October, 2011., 2011
  • Generic Medications: Implications for Persons with Epilepsy. Nebraska Epilepsy Support Group. Omaha, Nebraska. June 21, 2011. (Laypersons), 2011
  • Recognizing and Treating Depression in the Parkinson’s Disease Patient. Fourth Annual Parkinson’s Symposium: Optimal Care in Parkinson’s Disease. North Platte, Nebraska. May 27, 2011. (Invited), 2011
  • Vigabatrin (Sabril®). Epilepsy Conference. May 17, 2011., 2011

Research and Scholarship

Research and Scholarship Interests

  • 1. Neurology (focus in Parkinson’s disease, epilepsy, multiple sclerosis, stroke and headache disorders) 2. Geriatrics 3. Communication skills for students and practitioners

Grant Funding Received

  • Faulkner MA, Christensen K, Lenz TL. “Development of an interactive electronic health record as a training tool for pharmacy students.” Wide River TEC.
  • Threlkeld AJ, Xia R, Grindstaff TL, Faulkner MA, Fang X, Bertoni J. “Differentiation of central vs. peripheral fatigue in Parkinson’s disease.” 2012. US Department of Health and Human Services AREA Grant (R15).